CAPROCK Group Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 4.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,940 shares of the healthcare conglomerate’s stock after buying an additional 546 shares during the period. CAPROCK Group Inc.’s holdings in UnitedHealth Group were worth $6,089,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Palisades Hudson Asset Management L.P. increased its holdings in UnitedHealth Group by 2.0% during the 4th quarter. Palisades Hudson Asset Management L.P. now owns 1,078 shares of the healthcare conglomerate’s stock valued at $542,000 after purchasing an additional 21 shares during the period. Charter Oak Capital Management LLC increased its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock worth $442,000 after purchasing an additional 21 shares in the last quarter. Oxford Financial Group Ltd. increased its stake in UnitedHealth Group by 3.0% in the 4th quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock worth $362,000 after buying an additional 21 shares in the last quarter. Donald L. Hagan LLC raised its holdings in UnitedHealth Group by 1.2% during the fourth quarter. Donald L. Hagan LLC now owns 1,854 shares of the healthcare conglomerate’s stock valued at $931,000 after acquiring an additional 22 shares during the period. Finally, Guardian Wealth Advisors LLC raised its holdings in UnitedHealth Group by 2.1% during the fourth quarter. Guardian Wealth Advisors LLC now owns 1,075 shares of the healthcare conglomerate’s stock valued at $540,000 after acquiring an additional 22 shares during the period. 87.48% of the stock is owned by institutional investors.
In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Frederick William Mcnabb III purchased 89 shares of the firm’s stock in a transaction on Thursday, May 26th. The stock was acquired at an average cost of $504.32 per share, with a total value of $44,884.48. Following the transaction, the director now directly owns 11,259 shares in the company, valued at $5,678,138.88. The disclosure for this purchase can be found here. Company insiders own 0.40% of the company’s stock.
UNH opened at $489.68 on Thursday. The company has a market cap of $459.40 billion, a PE ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a 50-day moving average price of $496.56 and a 200 day moving average price of $490.86.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The company had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.31 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th will be issued a dividend of $1.65 per share. The ex-dividend date is Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.35%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.